Neos Therapeutics CEO Gerald McLaughlin's 2019 pay falls 56% to $1.4M
Neos Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 21, 2020
Neos Therapeutics reported fiscal year 2019 executive compensation information on April 21, 2020.
In 2019, three executives at Neos Therapeutics received on average a compensation package of $950K, a 42% decrease compared to previous year.
Average pay of disclosed executives at Neos Therapeutics
Gerald McLaughlin, Chief Executive Officer, received $1.4M in total, which decreased by 56% compared to 2018. 43% of McLaughlin's compensation, or $605K, was in option awards. McLaughlin also received $42K in bonus, $227K in non-equity incentive plan, $513K in salary, as well as $13K in other compensation.
Richard Eisenstadt, Chief Financial Officer, received a compensation package of $837K, which is about the same as previous year. 43% of the compensation package, or $359K, was in salary.
John M. Limongelli, General Counsel, earned $612K in 2019.
Related executives
You may also like
Source: SEC filing on April 21, 2020.